AbCellera Biologics Inc Settles Patent Litigation with Bruker — TradingView News

Litigation, Intellectual Property News

On December 18, 2025, AbCellera Biologics Inc announced a global settlement and patent license agreement with Bruker Corporation.

Source

Litigation, Intellectual Property

CATEGORY

Dec 18, 2025

PUBLISHED DATE

1

No.of views

Related articles